-
patient-informed treatment priorities. To achieve this, POLARIS brings together expertise in leukodystrophy biology, advanced disease models, therapeutic innovation, biomarker development, clinical
-
treatment priorities. To achieve this, POLARIS brings together expertise in leukodystrophy biology, advanced disease models, therapeutic innovation, biomarker development, clinical translation, patient
-
patient-informed treatment priorities. To achieve this, POLARIS brings together expertise in leukodystrophy biology, advanced disease models, therapeutic innovation, biomarker development, clinical
-
estimation of 3D coronary hemodynamics (velocity, pressure, and wall shear stress fields); design computational pipelines that integrate image-based anatomy, blood flow physics, and uncertainty quantification
-
expertise in leukodystrophy biology, advanced disease models, therapeutic innovation, biomarker development, clinical translation, patient engagement, and ethical, regulatory and health-economic aspects
-
countries (HIC). The airm of this PhD project is to understand how E. coli colonization contributes tot he risk of diarrheal disease and infections with AMR and use this knowledge to design interventions